Patrick Ryan, MD
Neurological Surgery · Montgomery, ALNPI 1649346784
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Cerapedics Inc. at 43.8% of the total. Reporting peaked in 2021 at $4,572 and has fallen 86.6% since, to $613 in 2025.
Across 114 payments — averaging $75.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cerapedics Inc.$4K
- Spinal Elements, Inc.$2K
- Abbott$1K
- Providence Medical Technology, Inc.$653
- Orthofix Medical, Inc.$204
- Si-bone, Inc.$188
- plus $1K from 16 others
What the payments were for
- Royalty or licence$1,39716%
- Speaking & faculty fees$1,50018%
- Travel & lodging$1,79221%
- Food & beverage$3,81545%
- Education$651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cerapedics Inc. | 9 | $3,757 |
| Spinal Elements, Inc. | 5 | $1,538 |
| Abbott | 38 | $1,174 |
| Providence Medical Technology, Inc. | 8 | $653 |
| Orthofix Medical, Inc. | 9 | $204 |
| Si-bone, Inc. | 7 | $188 |
| Globus Medical(2 entities) | 4 | $171 |
| Zimmer Biomet | 3 | $142 |
| Arteriocyte Medical Systems, Inc. | 2 | $140 |
| Kyocera Medical Technologies, Inc. | 1 | $119 |
| Arbor Pharmaceuticals, Inc. | 4 | $72 |
| Nevro Corp. | 4 | $69 |
| Portola Pharmaceuticals, LLC | 5 | $65 |
| Boston Scientific | 4 | $55 |
| Medtronic(2 entities) | 2 | $46 |
| Kls-martin L.p. | 2 | $40 |
| Baxter Healthcare | 1 | $35 |
| Radius Health, Inc. | 2 | $34 |
| Johnson & Johnson | 1 | $19 |
| Convatec Inc. | 1 | $17 |
| Sobi, Inc | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$11,077
- Medical Device$1,397
- PROCLAIM$354
- ETERNA$127
- Accelero-None$123
- Proclaim IPG$108
- Magellan$108
How this compares
$8,569 in reported general payments places this provider in the 75th percentile of 97 neurological surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 149 | $1,640 |
| Celecoxib | 15 | $338 |
| Gabapentin | 27 | $333 |
| Methocarbamol | 20 | $308 |
| Tramadol Hcl | 45 | $178 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $112 |
| Cyclobenzaprine Hcl | 11 | $85 |
| Meloxicam | 14 | $36 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Montgomery
- Ninh DoanMontgomery$9K
- John JohnsonHuntsville$250K
- Cheng TaoHuntsville$236K
- Mark HadleyBirmingham$104K
- Andrew ErwoodBirmingham$85K
- Marshall HollandBirmingham$81K
- Joel PickettHuntsville$72K
- Richard MengerMobile$70K
- Jason BanksHuntsville$65K
- Jakub GodzikBirmingham$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.